AB

Aaron Bartlone

Chief Operating Officer

Cybin Inc.

Alpharetta, Georgia


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Cybin Inc.
Industry
research
Employees
78.0
Seniority
C suite
Annual Revenue
60000.0

Technologies

Outlook Microsoft Office 365 Cloudflare DNS CloudFlare Hosting Facebook Widget WordPress.org Google Tag Manager Facebook Login (Connect) Mobile Friendly Nginx Shutterstock ON24 New Relic Facebook Custom Audiences reCAPTCHA BugHerd Google Analytics Google Font API Vimeo Linkedin Marketing Solutions Remote AI Basis Data Analytics

Keywords

biotech psychedelics science ecommerce nutraceutical digital marketing mushrooms mental health drug development capital direct to consumer retail supplements medicine active pharmaceutical ingredients pharmaceutical marketing nootropics psilocybin plants life sciences biotechnology: pharmaceutical preparations health care biotechnology research psychedelic therapy mental health treatments depression anxiety breakthrough therapy designation cyb003 cyb004 5-ht receptor agonists novel drug delivery systems clinical trials intellectual property safety & efficacy bioavailability neuropsychiatry serotonin psychedelic compounds cns disorders functional imaging drug discovery substance use disorders therapeutic outcomes treatment regimens dmt psilocin intramuscular dosing oral medication risk management patient compliance phase 2 clinical trials fda approval serotonergic therapy deuterated compounds clinical pharmacology patient care novel formulations mindfulness techniques trauma-informed care research partnerships facilitator training embark program patient-centered care mental health innovation longitudinal studies quantitative measurements 5-ht2a receptor cognitive behavioral therapy patient safety mental health access cns therapeutics psychedelic therapeutics mental health treatment innovative drug delivery systems proprietary drug discovery major depressive disorder generalized anxiety disorder ptsd treatment chronic pain management fda breakthrough therapy designation deuterated psilocybin novel formulation approaches patient-centered therapies mental health disorders research & development personalized medicine treatment-resistant depression ethical biopharmaceuticals psychedelic medicine industry mental healthcare revolution strategic partnerships clinical validation innovative therapies long-lasting treatment effects unmet medical needs e-commerce consumer internet consumers internet information technology & services marketing & advertising hospital & health care medical health wellness & fitness

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans